Published in Disease Risk Factor Week, August 1st, 2004
The instrument is used as a pre-screen in the early detection of glaucoma, cataract, and age-related macular degeneration (AMD), the three leading causes of eye disease and blindness.
"The FTA will reduce the time needed by optometrists and ophthalmologists conducting autoperimetry tests by more than 40%," said Paradigm Medical's Chief Executive Officer, John Yoon. "The procedure currently takes more than 15 minutes."
"The LD400 FT is the latest installment in the company's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.